Prophylaxis and treatment of venous thromboembolism in patients with cancer: the Saudi clinical practice guideline

Annals of Saudi Medicine
Fahad Al-HameedElie A Akl

Abstract

Venous thromboembolism (VTE) is commonly encountered in the daily clinical practice. Cancer is an important VTE risk factor. Proper thromboprophylaxis is key to prevent VTE in patients with cancer, and proper treatment is essential to reduce VTE complications and adverse events associated with the therapy. As a result of an initiative of the Ministry of Health of Saudi Arabia, an expert panel led by the Saudi Association for Venous Thrombo-Embolism (a subsidiary of the Saudi Thoracic Society) and the Saudi Scientific Hematology Society with the methodological support of the McMaster University working group produced this clinical practice guideline to assist health care providers in evidence-based clinical decision-making for VTE prophylaxis and treatment in patients with cancer. Six questions related to thromboprophylaxis and antithrombotic therapy were identified and the corresponding recommendations were made following the GRADE (Grading of Recommendations, Assessment, Development and Evaluation) approach. Question 1. Should heparin versus no heparin be used in outpatients with cancer who have no other therapeutic or prophylactic indication for anticoagulation? For outpatients with cancer, the Saudi Expert Panel suggests aga...Continue Reading

References

Oct 20, 1998·Archives of Internal Medicine·L HarrisonJ Hirsh
Jul 11, 2003·The New England Journal of Medicine·Agnes Y Y LeeUNKNOWN Randomized Comparison of Low-Molecular-Weight Heparin versus Oral Anticoagulant Therapy for the Prevention of Recurrent Veno
May 4, 2004·Scandinavian Journal of Primary Health Care·Karin BäckmanClaes Hallert
Feb 11, 2005·JAMA : the Journal of the American Medical Association·Jeanet W BlomFrits R Rosendaal
Sep 8, 2005·The Journal of Urology·Joseph A Smith
Jul 21, 2006·Pathophysiology of Haemostasis and Thrombosis·Frederick R Rickles
Sep 27, 2006·Clinical and Applied Thrombosis/hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis·Steven R DeitcherUNKNOWN ONCENOX Investigators
Dec 6, 2006·The American Journal of Medicine·Russell D HullUNKNOWN LITE Trial Investigators
Jan 9, 2007·The American Journal of Medicine·Russell D HullUNKNOWN LITE Trial Investigators
Oct 31, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Gary H LymanUNKNOWN American Society of Clinical Oncology
Jan 6, 2009·European Journal of Vascular and Endovascular Surgery : the Official Journal of the European Society for Vascular Surgery·A RomeraO Lapiedra
Jul 29, 2009·The American Journal of Medicine·Russell D HullUNKNOWN LITE Trial Investigators
Jan 5, 2011·Journal of Clinical Epidemiology·Gordon GuyattHolger J Schünemann
Jan 7, 2011·Journal of Clinical Epidemiology·Howard BalshemGordon H Guyatt
Apr 20, 2011·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Frederiek F van DoormaalHarry R Buller
Jun 17, 2011·The Cochrane Database of Systematic Reviews·Elie A AklHolger Schünemann
Jul 1, 2011·Journal of the National Comprehensive Cancer Network : JNCCN·Alok A Khorana
Nov 22, 2011·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·A MaraveyasG Bozas
Feb 18, 2012·The New England Journal of Medicine·Giancarlo AgnelliUNKNOWN SAVE-ONCO Investigators
Mar 14, 2012·Journal of Thrombosis and Haemostasis : JTH·M N LevineJ Julian
Apr 13, 2012·Lancet·Samuel Z Goldhaber, Henri Bounameaux
Jul 4, 2012·International Journal of Cancer. Journal International Du Cancer·Freddie BrayJacques Ferlay
Jul 18, 2012·Asian Pacific Journal of Cancer Prevention : APJCP·Aamer AleemMohamed Sherif El-Sherkawy
Jan 15, 2013·Journal of Clinical Epidemiology·Jeff AndrewsHolger J Schünemann
Oct 1, 2010·The Saudi Dental Journal·Abdullah M Aldrees, Saad M Al-Manea
Aug 21, 2013·Saudi Pharmaceutical Journal : SPJ : the Official Publication of the Saudi Pharmaceutical Society·Farjah AlgahtaniAamer Aleem
Jun 20, 2014·The Cochrane Database of Systematic Reviews·Elie A AklHolger Schünemann
Jul 9, 2014·The Cochrane Database of Systematic Reviews·Elie A AklHolger Schünemann
Oct 2, 2014·The New England Journal of Medicine·Lorenzo D'AmbrosioGiovanni Grignani
Oct 16, 2014·The Cochrane Database of Systematic Reviews·Elie A AklHolger Schünemann
Jan 22, 2015·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Gary H LymanUNKNOWN American Society of Clinical Oncology

❮ Previous
Next ❯

Citations

Apr 27, 2019·Clinical and Applied Thrombosis/hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis·Jiuxing ZhangZhigang Zhao
Aug 31, 2017·Health and Quality of Life Outcomes·Anna SelvaPablo Alonso-Coello
Oct 6, 2018·European Journal of Cardio-thoracic Surgery : Official Journal of the European Association for Cardio-thoracic Surgery·Chunfeng SongBin Hu
Feb 20, 2021·Journal of Multidisciplinary Healthcare·Saja H AlmazrouSharifah M Ghazwani

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.